ERBB2 and breast carcinoma: In some breast cancer patient cohorts such as high-grade, ER− or basal-like and HER2 subtypes, high CES either: (1) did not have significant prognostic value or (2) predicted better survival (Fig. 5; Supplementary Figs 12–14).